Protection of p53 wild type cells from taxol by nutlin-3 in the combined lung cancer treatment.
about
The p53 circuit boardEffects of 5-fluorouracil on morphology, cell cycle, proliferation, apoptosis, autophagy and ROS production in endothelial cells and cardiomyocytesiASPP is over-expressed in human non-small cell lung cancer and regulates the proliferation of lung cancer cells through a p53 associated pathway.Suppression of eukaryotic initiation factor 4E prevents chemotherapy-induced alopeciaAn evaluation of small-molecule p53 activators as chemoprotectants ameliorating adverse effects of anticancer drugs in normal cells.Pharmacologic activation of p53 by small-molecule MDM2 antagonistsThe structure-based design of Mdm2/Mdmx-p53 inhibitors gets seriousMdm2 inhibition confers protection of p53-proficient cells from the cytotoxic effects of Wee1 inhibitorsThe MDM2-inhibitor Nutlin-3 synergizes with cisplatin to induce p53 dependent tumor cell apoptosis in non-small cell lung cancerHistone deacetylase inhibitors enhance the anticancer activity of nutlin-3 and induce p53 hyperacetylation and downregulation of MDM2 and MDM4 gene expression.MDM2 Antagonists Counteract Drug-Induced DNA Damage.Combretastatin A-4 induces p53 mitochondrial-relocalisation independent-apoptosis in non-small lung cancer cells.
P2860
Q28259725-163564AD-C740-4382-8024-2B4DA4890E58Q28543397-91A3C059-20B4-484B-8159-20245330F1CBQ33782345-5110C933-8C25-4741-8C87-BEA342D3D502Q34479333-A14B5157-DB37-484D-A52D-17C2D0655178Q36023740-D47405B8-C3CD-4E23-AAA6-1E068D55B458Q36731603-109DFBA4-95DE-45D2-9F5B-87DB74131EFAQ37845797-513166B6-F713-4F35-A63B-9B1B1ED65A37Q38261022-CA641FAC-A4C7-4640-AD35-265CD735E1C5Q38858580-416D800B-49F9-4F1E-8DC3-2E40FFF1F704Q39672349-3C0FEC8B-EC81-4F68-AA08-289C46296863Q42651903-DD6F7646-3D34-4CA4-ACE8-D5B79CB1BE30Q53085465-BFC2DCB6-4C59-4454-8B94-ADCADAD5FC86
P2860
Protection of p53 wild type cells from taxol by nutlin-3 in the combined lung cancer treatment.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Protection of p53 wild type ce ...... ombined lung cancer treatment.
@ast
Protection of p53 wild type ce ...... ombined lung cancer treatment.
@en
Protection of p53 wild type ce ...... ombined lung cancer treatment.
@nl
type
label
Protection of p53 wild type ce ...... ombined lung cancer treatment.
@ast
Protection of p53 wild type ce ...... ombined lung cancer treatment.
@en
Protection of p53 wild type ce ...... ombined lung cancer treatment.
@nl
prefLabel
Protection of p53 wild type ce ...... ombined lung cancer treatment.
@ast
Protection of p53 wild type ce ...... ombined lung cancer treatment.
@en
Protection of p53 wild type ce ...... ombined lung cancer treatment.
@nl
P2860
P356
P1433
P1476
Protection of p53 wild type ce ...... ombined lung cancer treatment.
@en
P2093
Nasreddin D Abolmaali
P2860
P2888
P356
10.1186/1471-2407-10-57
P407
P577
2010-02-23T00:00:00Z
P5875
P6179
1046663325